The Essentials of Multiomics

Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificia...

Full description

Saved in:
Bibliographic Details
Published in:The oncologist (Dayton, Ohio) Ohio), 2022-04, Vol.27 (4), p.272-284
Main Authors: Marshall, John L, Peshkin, Beth N, Yoshino, Takayuki, Vowinckel, Jakob, Danielsen, Håvard E, Melino, Gerry, Tsamardinos, Ioannis, Haudenschild, Christian, Kerr, David J, Sampaio, Carlos, Rha, Sun Young, FitzGerald, Kevin T, Holland, Eric C, Gallagher, David, Garcia-Foncillas, Jesus, Juhl, Hartmut
Format: Article
Language:English
Subjects:
Antimitotic agents
Antineoplastic agents
Artificial Intelligence
Cancer Diagnostics and Molecular Pathology
Genes
Genomics
Humans
Machine learning
Medical Oncology
Neoplasms - genetics
Neoplasms - therapy
Proteomics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificial intelligence are now commonplace, and this rapid evolution has left us with a significant knowledge gap within the medical community. In this paper, we attempt to bridge that gap and prepare the physician in oncology for multiomics, a group of technologies that have gone from looming on the horizon to become a clinical reality. The era of multiomics is here, and we must prepare ourselves for this exciting new age of cancer medicine.
ISSN:1083-7159
1549-490X
1549-490X
DOI:10.1093/oncolo/oyab048